John L. Darling

Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties

Nga Chi Yip, Ivo S. Fombon, P Liu et al. · British Journal of Cancer · 2011 · 425 citations · Full text

Medicine, Oncology, Pharmacology +16

Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells

P Liu, Indresh Kumar, Vinodh Kannappan et al. · British Journal of Cancer · 2013 · 210 citations · Full text

Medicine, Oncology, Pharmacology +16

Characterization of the human cell line TE671

Michael R. Stratton, John L. Darling, Gerlinde Pilkington et al. · Carcinogenesis · 1989 · 163 citations

Medicine, Genetics, Oncology +15

Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines

Xiaoxia Guo, Bing Xu, Shuchita Pandey et al. · Cancer Letters · 2009 · 135 citations

Medicine, Oncology, Pharmacology +9

Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells<i>in vitro</i>and<i>in vivo</i>

Peng Liu, Zhipeng Wang, Vinodh Kannappan et al. · Oncotarget · 2014 · 121 citations · Full text

Medicine, Oncology, Pharmacology +17